Middle East and Africa Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Middle East and Africa Blood Glucose Test Strip Market Share and It is Segmented by Product Type (self-Monitoring Blood Glucose, Continuous Glucose Monitoring), End User (Hospital/clinics and Home/Personal), and Geography (Saudi Arabia, Egypt, Oman, South Africa, Rest of Middle East and Africa). the Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Middle East and Africa Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Middle East and Africa Blood Glucose Monitoring Market Size

View Global Report
Middle East And Africa Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 4.71 Million
Market Size (2030) USD 7.10 Million
CAGR (2025 - 2030) 8.55 %

Major Players

Middle East And Africa Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Middle East And Africa Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Middle East and Africa Blood Glucose Monitoring Market Analysis

The Middle East And Africa Blood Glucose Monitoring Market size is estimated at USD 4.71 million in 2025, and is expected to reach USD 7.10 million by 2030, at a CAGR of greater than 8.55% during the forecast period (2025-2030).

Diabetes and COVID-19 have a significant influence on public health not just overseas but also in the Middle East and Africa. In COVID-19 patients, diabetes has been reported to increase the incidence of both fatal infections and serious infections. Because diabetes is one of the primary health issues that is incredibly prevalent in the Middle East and African countries, the present research focused on understanding the epidemiology of COVID-19 in people with diabetes and the initiatives put in place by the governments to decrease its impact.

There is an increasing incidence of lifestyle diseases, such as diabetes, in developing countries that are increasing the demand for blood glucose monitoring devices. The increased awareness about healthcare facilities and preventive care is also supporting the growth of the market. The number of patients relying on self-monitoring blood glucose (SMBG) has increased. Owing to the high-cost constraints associated with continuous glucose monitoring (CGM), self-monitoring by glucometer is more acceptable in the Middle-East and Africa region. These devices help in the early detection of hypo and hyperglycemia conditions, which tend to drive the market for glucose monitoring.

Middle East and Africa Blood Glucose Monitoring Industry Overview

The Middle East and Africa blood glucose monitoring market is highly fragmented, with few major manufacturers boasting a global market presence, while the remaining manufacturers are confined to other local or region-specific manufacturers, and local government initiatives encourage the market.

Middle East and Africa Blood Glucose Monitoring Market Leaders

  1. Medtronic

  2. Dexcom

  3. Johnson & Johnson

  4. F. Hoffmann-La Roche AG

  5. Abbott

  6. *Disclaimer: Major Players sorted in no particular order
Middle East And Africa Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Middle East and Africa Blood Glucose Monitoring Market News

  • August 2022: Abbott and WW International, Inc. (WeightWatchers) announced a strategic partnership to help people living with diabetes better understand and manage their diabetes and weight. The companies are working together to integrate WeightWatchers' diabetes-tailored weight management program with Abbott's portfolio of FreeStyle Libre products to create a seamless mobile experience that was expected to give people living with diabetes the information and insights needed to make healthy adjustments to their diet, improve their glucose levels, and, ultimately, gain more control of their health.
  • February 2022: The Oman Diabetes Association (ODA), in collaboration with the MOHs National Diabetes and Endocrine Center, launched the Nahnu Ma'akum (We Are With You) Initiative at the Ministry's headquarters. The initiative aimed to provide in-kind medical devices for social security children with diabetes across the Sultanate's governorates within a specific mechanism. The ODA's first initiative contributes to enhancing good control of the disease in this category, thus avoiding complications.

Middle East and Africa Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Device
    • 5.1.1 Self-monitoring Blood Glucose
    • 5.1.1.1 Glucometer Devices
    • 5.1.1.2 Test Strips
    • 5.1.1.3 Lancets
    • 5.1.2 Continuous Glucose Monitoring
    • 5.1.2.1 Sensors
    • 5.1.2.2 Durables
  • 5.2 End User
    • 5.2.1 Hospital/Clinics
    • 5.2.2 Home/Personal
  • 5.3 Geography
    • 5.3.1 Saudi Arabia
    • 5.3.2 Iran
    • 5.3.3 Egypt
    • 5.3.4 Oman
    • 5.3.5 South Africa
    • 5.3.6 Rest of Middle-East and Africa

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott
    • 7.1.2 F. Hoffmann-La Roche AG
    • 7.1.3 Johnson & Johnson
    • 7.1.4 Dexcom
    • 7.1.5 Medtronics
    • 7.1.6 Agamatrix Inc.
    • 7.1.7 Bionime Corporation
    • 7.1.8 Acon
    • 7.1.9 Medisana
    • 7.1.10 Trivida
    • 7.1.11 I-SENS
    • 7.1.12 Ascensia
    • 7.1.13 Rossmax
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
* We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents. **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Middle East and Africa Blood Glucose Monitoring Industry Segmentation

Using a glucose meter to measure the amount of glucose in the blood (glycemia) is known as blood glucose monitoring. A blood glucose test is normally conducted by piercing the skin (often via fingerstick) to extract blood, then putting the blood on a chemically active disposable "test strip," which is particularly significant in the treatment of diabetes. Continuous glucose monitoring (CGM) is the primary alternative. While different manufacturers employ various technologies, the majority of devices monitor an electrical characteristic and utilize this information to calculate the blood glucose level. The Middle East and Africa blood glucose monitoring market is segmented by product type (self-monitoring blood glucose, continuous glucose monitoring), End User (Hospital/clinics and Home/Personal), and geography (Saudi Arabia, Egypt, Oman, South Africa, and the rest of the Middle East and Africa). The report offers the value (in USD) and volume (in units) for the above segments. We will provide a segment-wise breakdown (value and volume) for all the countries covered under the Table of Contents.

Device Self-monitoring Blood Glucose Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Durables
End User Hospital/Clinics
Home/Personal
Geography Saudi Arabia
Iran
Egypt
Oman
South Africa
Rest of Middle-East and Africa
Need A Different Region or Segment?
Customize Now

Middle East and Africa Blood Glucose Monitoring Market Research FAQs

How big is the Middle East And Africa Blood Glucose Monitoring Market?

The Middle East And Africa Blood Glucose Monitoring Market size is expected to reach USD 4.71 million in 2025 and grow at a CAGR of greater than 8.55% to reach USD 7.10 million by 2030.

What is the current Middle East And Africa Blood Glucose Monitoring Market size?

In 2025, the Middle East And Africa Blood Glucose Monitoring Market size is expected to reach USD 4.71 million.

Who are the key players in Middle East And Africa Blood Glucose Monitoring Market?

Medtronic, Dexcom, Johnson & Johnson, F. Hoffmann-La Roche AG and Abbott are the major companies operating in the Middle East And Africa Blood Glucose Monitoring Market.

What years does this Middle East And Africa Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the Middle East And Africa Blood Glucose Monitoring Market size was estimated at USD 4.31 million. The report covers the Middle East And Africa Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Middle East And Africa Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Middle East and Africa Blood Glucose Monitoring Industry Report

Statistics for the 2025 Middle East And Africa Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Middle East And Africa Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Middle East and Africa Blood Glucose Monitoring Market Report Snapshots